Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Name: Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
License: Public Domain

Cumberland Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

gram infections

infections, gram-positive bacterial

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 136362
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.